Abstract
Silver (Ag) has been known for its antimicrobial properties for centuries but has received renewed interest in recent years primarily due to the rise of antibiotic-resistance and the development of Ag nanoparticles (AgNPs). In orthopedics, multiple applications containing Ag are being developed including Ag dressings, Ag-coated prosthetic implants, and Ag-based bone cements. In this chapter, we review the antimicrobial mechanisms as well as the delivery and metabolic pathways of Ag and the primary uses of Ag and AgNPs in orthopedic applications, focusing on their antimicrobial activity, toxicity, and clinical uses.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lansdown AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol. 2006;33:17–34.
Li B, Webster TJ. Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections. J Orthop Res 2017. https://doi.org/10.1002/jor.23656.
Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010;28(11):580–8.
Chernousova S, Epple M. Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed Engl. 2013;52(6):1636–53.
Drake PL, Hazelwood KJ. Exposure-related health effects of silver and silver compounds: a review. Ann Occup Hyg. 2005;49(7):575–85.
Gunawan C, Marquis CP, Amal R, Sotiriou GA, Rice SA, Harry EJ. Widespread and indiscriminate nanosilver use: genuine potential for microbial resistance. ACS Nano. 2017;11(4):3438–45.
Walker M, Parsons D. The biological fate of silver ions following the use of silver-containing wound care products—a review. Int Wound J. 2014;11(5):496–504.
National Collaborating Centre for Ws, Children’s H. National Institute for Health and Clinical Excellence: guidance. Surgical site infection: prevention and treatment of surgical site infection. London: RCOG Press National Collaborating Centre for Women’s and Children’s Health; 2008.
Leaper D. Appropriate use of silver dressings in wounds: an expert working group consensus. Wounds Int. 2012;9(5):461–4.
Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, Huang L. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen. 2007;15(1):94–104.
Parsons D, Meredith K, Rowlands VJ, Short D, Metcalf DG, Bowler PG. Enhanced performance and mode of action of a novel antibiofilm hydrofiber(R) wound dressing. Biomed Res Int. 2016;2016:7616471. PMCID:PMC5136405
Ip M, Lui SL, Poon VKM, Lung I, Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol. 2006;55(1):59–63.
Bourdillon KA, Delury CP, Cullen BM. Biofilms and delayed healing—an in vitro evaluation of silver- and iodine-containing dressings and their effect on bacterial and human cells. Int Wound J 2017. https://doi.org/10.1111/iwj.12761.
Mohseni M, Shamloo A, Aghababaei Z, Vossoughi M, Moravvej H. Antimicrobial wound dressing containing silver sulfadiazine with high biocompatibility: in vitro study. Artif Organs. 2016;40(8):765–73.
Lin YH, Hsu WS, Chung WY, Ko TH, Lin JH. Silver-based wound dressings reduce bacterial burden and promote wound healing. Int Wound J. 2016;13(4):505–11.
Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different wound dressings on cell viability and proliferation. Plast Reconstr Surg. 2006;117(7 Suppl):110S–8S. discussion 9S–20S
Hiro ME, Pierpont YN, Ko F, Wright TE, Robson MC, Payne WG. Comparative evaluation of silver-containing antimicrobial dressings on in vitro and in vivo processes of wound healing. Eplasty. 2012;12:e48. PMCID:PMC3471607
Gee Kee E, Stockton K, Kimble RM, Cuttle L, McPhail SM. Cost-effectiveness of silver dressings for paediatric partial thickness burns: an economic evaluation from a randomized controlled trial. Burns. 2017;43(4):724–32.
Munteanu A, Florescu IP, Nitescu C. A modern method of treatment: the role of silver dressings in promoting healing and preventing pathological scarring in patients with burn wounds. J Med Life. 2016;9(3):306–15. PMCID:PMC5154321
Jude EB, Apelqvist J, Spraul M, Martini J. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabet Med. 2007;24(3):280–8.
Jemec GB, Kerihuel JC, Ousey K, Lauemoller SL, Leaper DJ. Cost-effective use of silver dressings for the treatment of hard-to-heal chronic venous leg ulcers. PLoS One. 2014;9(6):e100582. PMCID:PMC4063949
Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplast. 2008;23(7):984–91.
Lamagni T. Epidemiology and burden of prosthetic joint infections. J Antimicrob Chemother. 2014;69(Suppl 1):i5–10.
Grosso MJ, Berg A, LaRussa S, Murtaugh T, Trofa DP, Geller JA. Silver-impregnated occlusive dressing reduces rates of acute periprosthetic joint infection after total joint arthroplasty. J Arthroplast. 2017;32(3):929–32.
Cai J, Karam JA, Parvizi J, Smith EB, Sharkey PF. Aquacel surgical dressing reduces the rate of acute PJI following total joint arthroplasty: a case-control study. J Arthroplast. 2014;29(6):1098–100.
Springer BD, Beaver WB, Griffin WL, Mason JB, Odum SM. Role of surgical dressings in total joint arthroplasty: a randomized controlled trial. Am J Orthop (Belle Mead NJ). 2015;44(9):415–20.
Ravenscroft MJ, Harker J, Buch KA. A prospective, randomised, controlled trial comparing wound dressings used in hip and knee surgery: aquacel and tegaderm versus cutiplast. Ann R Coll Surg Engl. 2006;88(1):18–22.
Jurczak F, Dugre T, Johnstone A, Offori T, Vujovic Z, Hollander D. Randomised clinical trial of Hydrofiber dressing with silver versus povidone-iodine gauze in the management of open surgical and traumatic wounds. Int Wound J. 2007;4(1):66–76.
Keen JS, Desai PP, Smith CS, Suk M. Efficacy of hydrosurgical debridement and nanocrystalline silver dressings for infection prevention in type II and III open injuries. Int Wound J. 2012;9(1):7–13.
Kadar A, Eisenberg G, Yahav E, Drexler M, Salai M, Steinberg EL. Surgical site infection in elderly patients with hip fractures, silver-coated versus regular dressings: a randomised prospective trial. J Wound Care. 2015;24(10):441–2. 4–5
Fries CA, Ayalew Y, Penn-Barwell JG, Porter K, Jeffery SL, Midwinter MJ. Prospective randomised controlled trial of nanocrystalline silver dressing versus plain gauze as the initial post-debridement management of military wounds on wound microbiology and healing. Injury. 2014;45(7):1111–6.
Muller ME. Internal fixation for fresh fractures and for non-union. Proc R Soc Med. 1963;56:455–60. PMCID:PMC1897011
Harris WH, Sledge CB. Total hip and total knee replacement. N Engl J Med. 1990;323(11):725–31.
Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422–9.
Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis. 2006;19(4):349–56.
Ribeiro M, Monteiro FJ, Ferraz MP. Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter. 2012;2(4):176–94.
Coester LM, Nepola JV, Allen J, Marsh JL. The effects of silver coated external fixation pins. Iowa Orthop J. 2006;26:48–53. PMCID:PMC1888577
Masse A, Bruno A, Bosetti M, Biasibetti A, Cannas M, Gallinaro P. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J Biomed Mater Res. 2000;53(5):600–4.
Wassall MA, Santin M, Isalberti C, Cannas M, Denyer SP. Adhesion of bacteria to stainless steel and silver-coated orthopedic external fixation pins. J Biomed Mater Res. 1997;36(3):325–30.
Collinge CA, Goll G, Seligson D, Easley KJ. Pin tract infections: silver vs uncoated pins. Orthopedics. 1994;17(5):445–8.
Bosetti M, Masse A, Tobin E, Cannas M. Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. Biomaterials. 2002;23(3):887–92.
Gkavardina A, Tsagozis P. The use of megaprostheses for reconstruction of large skeletal defects in the extremities: a critical review. Open Orthop J. 2014;8:384–9.
Schmidt-Braekling T, Streitbuerger A, Gosheger G, Boettner F, Nottrott M, Ahrens H, Dieckmann R, Guder W, Andreou D, Hauschild G, Moellenbeck B, Waldstein W, Hardes J. Silver-coated megaprostheses: review of the literature. Eur J Orthop Surg Traumatol. 2017;27(4):483–9.
Ewald A, Glückermann SK, Thull R, Gbureck U. Antimicrobial titanium/silver PVD coatings on titanium. BioMed Eng Online. 2006;5:22.
Hardes J, Streitburger A, Ahrens H, Nusselt T, Gebert C, Winkelmann W, Battmann A, Gosheger G. The influence of elementary silver versus titanium on osteoblasts behaviour in vitro using human osteosarcoma cell lines. Sarcoma. 2007;2007:26539. PMCID:PMC1920591
Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M, Gunsel A, Kemper FH, Winkelmann W, Von Eiff C. Silver-coated megaendoprostheses in a rabbit model—an analysis of the infection rate and toxicological side effects. Biomaterials. 2004;25(24):5547–56.
Wafa H, Grimer RJ, Reddy K, Jeys L, Abudu A, Carter SR, Tillman RM. Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. Bone Joint J. 2015;97-b(2):252–7.
Hardes J, von Eiff C, Streitbuerger A, Balke M, Budny T, Henrichs MP, Hauschild G, Ahrens H. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol. 2010;101(5):389–95.
Scoccianti G, Frenos F, Beltrami G, Campanacci DA, Capanna R. Levels of silver ions in body fluids and clinical results in silver-coated megaprostheses after tumour, trauma or failed arthroplasty. Injury. 2016;47(Suppl 4):S11–S6.
Glehr M, Leithner A, Friesenbichler J, Goessler W, Avian A, Andreou D, Maurer-Ertl W, Windhager R, Tunn PU. Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J. 2013;95-b(7):988–92.
Kose N, Caylak R, Peksen C, Kiremitci A, Burukoglu D, Koparal S, Dogan A. Silver ion doped ceramic nano-powder coated nails prevent infection in open fractures: In vivo study. Injury. 2016;47(2):320–4.
Secinti KD, Ozalp H, Attar A, Sargon MF. Nanoparticle silver ion coatings inhibit biofilm formation on titanium implants. J Clin Neurosci. 2011;18(3):391–5.
Vaishya R, Chauhan M, Vaish A. Bone cement. J Clin Orthop Trauma. 2013;4(4):157–63.
Spadaro JA, Webster DA, Becker RO. Silver polymethyl methacrylate antibacterial bone cement. Clin Orthop Relat Res. 1979;(143):266–70.
Dueland R, Spadaro JA, Rahn BA. Silver antibacterial bone cement. Comparison with gentamicin in experimental osteomyelitis. Clin Orthop Relat Res. 1982;169:264–8.
Alt V, Bechert T, Steinrucke P, Wagener M, Seidel P, Dingeldein E, Domann E, Schnettler R. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials. 2004;25(18):4383–91.
Oei JD, Zhao WW, Chu L, DeSilva MN, Ghimire A, Rawls HR, Whang K. Antimicrobial acrylic materials with in situ generated silver nanoparticles. J Biomed Mater Res B Appl Biomater. 2012;100(2):409–15.
Prokopovich P, Leech R, Carmalt CJ, Parkin IP, Perni S. A novel bone cement impregnated with silver-tiopronin nanoparticles: its antimicrobial, cytotoxic, and mechanical properties. Int J Nanomed. 2013;8:2227–37. PMCID:PMC3693822
Slane J, Vivanco J, Rose W, Ploeg HL, Squire M. Mechanical, material, and antimicrobial properties of acrylic bone cement impregnated with silver nanoparticles. Mater Sci Eng C Mater Biol Appl. 2015;48:188–96.
Moojen DJ, Vogely HC, Fleer A, Verbout AJ, Castelein RM, Dhert WJ. No efficacy of silver bone cement in the prevention of methicillin-sensitive Staphylococcal infections in a rabbit contaminated implant bed model. J Orthop Res. 2009;27(8):1002–7.
Acknowledgement
We acknowledge financial support from AO Foundation (Project S-13-15L was supported by the AO Foundation), Osteosynthesis & Trauma Care Foundation, the West Virginia National Aeronautics and Space Administration Experimental Program to Stimulate Competitive Research (WV NASA EPSCoR), NIH Grant P20GM103434, and the National Institute of General Medical Sciences of the National Institutes of Health under Award Number 2U54GM104942-02. This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program, Discovery Award under Award No. W81XWH-17-1-0603. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the funding agencies. We thank Suzanne Danley for proofreading.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Kang, J., Hughes, K., Xing, M., Li, B. (2017). Orthopedic Applications of Silver and Silver Nanoparticles. In: Li, B., Webster, T. (eds) Orthopedic Biomaterials. Springer, Cham. https://doi.org/10.1007/978-3-319-73664-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-73664-8_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73663-1
Online ISBN: 978-3-319-73664-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)